We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$107B
AUM Growth
-$4.74B
Cap. Flow
-$4.5B
Cap. Flow %
-4.19%
Top 10 Hldgs %
16.64%
Holding
4,289
New
314
Increased
1,937
Reduced
1,469
Closed
342

Sector Composition

Rank Sector Weight
1 Technology 12.27%
2 Financials 11.39%
3 Healthcare 9.26%
4 Consumer Discretionary 6.73%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWIR
3351
DELISTED
Sierra Wireless
SWIR
$383K ﹤0.01%
23,208
-4,210
-15% -$75.1K
BSM icon
3352
Black Stone Minerals
BSM
$3.18B
$382K ﹤0.01%
23,106
+4,759
+26% +$84.7K
RBCAA icon
3353
Republic Bancorp
RBCAA
$1.95B
$382K ﹤0.01%
9,992
+1,772
+22% +$69K
BOJA
3354
DELISTED
Bojangles', Inc. Common Stock
BOJA
$382K ﹤0.01%
27,610
+1,537
+6% +$19.8K
FLCA icon
3355
Franklin FTSE Canada ETF
FLCA
$805M
$381K ﹤0.01%
15,983
-33,000
-67% -$828K
HOME
3356
DELISTED
At Home Group Inc.
HOME
$381K ﹤0.01%
11,924
-1,785
-13% -$54.8K
DERM
3357
DELISTED
Dermira, Inc.
DERM
$381K ﹤0.01%
47,651
+8,946
+23% +$195K
MNOV icon
3358
MediciNova
MNOV
$65.5M
$380K ﹤0.01%
37,137
+26,794
+259% +$267K
DSKE
3359
DELISTED
Daseke, Inc. Common Stock
DSKE
$380K ﹤0.01%
38,781
+13,664
+54% +$163K
AMT icon
3360
PUT
American Tower
AMT
$80.8B
$378K ﹤0.01%
+2,600
New +$366K
TVRD
3361
Tvardi Therapeutics
TVRD
$19.7M
$377K ﹤0.01%
845
-887
-51% -$430K
LBTYA icon
3362
CALL
Liberty Global Class A
LBTYA
$3.62B
$376K ﹤0.01%
+12,000
New +$415K
RETA
3363
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$376K ﹤0.01%
18,344
+606
+3% +$15.6K
GPX
3364
DELISTED
GP Strategies Corp.
GPX
$376K ﹤0.01%
16,634
+3,951
+31% +$92.5K
MIME
3365
DELISTED
Mimecast Limited
MIME
$373K ﹤0.01%
10,520
-13,249
-56% -$450K
CNXN icon
3366
PC Connection
CNXN
$2.11B
$368K ﹤0.01%
14,745
+448
+3% +$11.6K
NIC icon
3367
Nicolet Bankshares
NIC
$3.6B
$368K ﹤0.01%
6,673
+2,381
+55% +$130K
MRTX
3368
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$368K ﹤0.01%
+11,992
New +$333K
ACBI
3369
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$368K ﹤0.01%
20,337
+3,684
+22% +$65.1K
SLYV icon
3370
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$367K ﹤0.01%
+5,940
New +$374K
SNDR icon
3371
Schneider National
SNDR
$6.26B
$367K ﹤0.01%
14,119
+2,079
+17% +$57.2K
ENBL
3372
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$367K ﹤0.01%
26,712
+8,056
+43% +$117K
ARCO icon
3373
Arcos Dorados Holdings
ARCO
$1.72B
$366K ﹤0.01%
41,113
-41,503
-50% -$389K
ZUMZ icon
3374
Zumiez
ZUMZ
$332M
$365K ﹤0.01%
15,281
+2,484
+19% +$53.1K
ACET
3375
DELISTED
Aceto Corp
ACET
$365K ﹤0.01%
48,226
+1,087
+2% +$9.5K

Similar funds

Credit Suisse's Q1 2018 Portfolio in Review

As of Q1 2018, Credit Suisse held 4,289 positions worth $107B, down 4.2% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $4.5B in Q1 2018, closing 342 positions and reducing 1,469 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $959M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Credit Suisse opened a new position in Cambria Shareholder Yield ETF worth $75.4M.

  • Credit Suisse's largest Q1 2018 buy was Cambria Shareholder Yield ETF: 2,000,000 shares worth $75.4M.
  • Credit Suisse added most to iShares Core S&P Mid-Cap ETF in Q1 2018, an estimated $731M increase.
  • Credit Suisse's biggest Q1 2018 reduction was UnitedHealth, cutting an estimated $1.54B.
  • Credit Suisse fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q1 2018, selling an estimated $959M.
  • Credit Suisse's ten largest holdings make up 17% of its $107B portfolio in Q1 2018.
  • Credit Suisse opened 314 new positions and closed 342 in Q1 2018.
  • Credit Suisse's portfolio value fell 4.2% quarter-over-quarter to $107B.

Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.